Hydrus Microstent – Micro-Invasive Glaucoma Surgery – Dr. Lewis
Serving Northeast Philadelphia, the Main Line, King of Prussia, Conshohocken, Philadelphia, Phoenixville, Willow Grove, Abington, and surrounding areas.
Hydrus® Microstent Fact Sheet
Facts about Hydrus:
- The device opens a bypass through the trabecular meshwork, a common site of aqueous blockage in the eye;
- It then dilates and scaffolds (keeps open) an important part of the eye called Schlemm’s canal to enhance flow; and
- The device spans a full 90 degrees within the canal. This coverage is designed to ensure that fluid reaches the eye’s drainage system, which carries fluid from Schlemm’s Canal in to the body’s circulatory system and allows pressure in the eye to be lowered
- In this pivotal study more than 78 percent of Hydrus Microstent patients remained medication-free compared to 48 percent in the control group, a 30 percent difference and the largest improvement versus control of any MIGS pivotal trial to date.
- Additionally Hydrus Microstent patients had a 43% lower intraocular pressure at 2 years compared to the control group
Facts about Glaucoma:
– Glaucoma is a leading cause of blindness and affects more than 70 million people worldwide; it is estimated that over 4 million patients have glaucoma in the United States.2 There is no cure for glaucoma, but its long term effects may be prevented with early detection, medication use and other treatments, including surgery.
Hydrus® Microstent Important Safety Information
CAUTION: Federal law restricts this device to sale by or on the order of a physician.
INDICATIONS FOR USE: